Cancer Research UK logo.
SearchDonate
  • Search

A trial of irinotecan, cisplatin and mitomycin C for advanced kidney cancer

Overview

Cancer types:

Kidney cancer, Renal cell cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at a combination of the chemotherapy drugs irinotecan, cisplatin and mitomycin C (IPM) for advanced kidney cancer. Advanced kidney cancer means the cancer has spread from where it first developed in the kidney.

Recruitment start: 12 March 2003

Recruitment end: 31 January 2011

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Jonathan Shamash

Supported by

Barts Health NHS Trust

Experimental Cancer Medicine Centre (ECMC)

Orchid Cancer Appeal

Last reviewed: 13 Jan 2016

CRUK internal database number: 2616

Help and support